Ecallantide

Create: 11/08/2018

Expired Date:	never
Category:	Drugs&Pharmaceutical [Health&Medical&Pharmaceutical]
Message:	HAE is caused by a mutation of the C1-inhibitor gene. Defective or missing C1-inhibitor permits activation of kallikrein, a protease that is responsible for liberating bradykinin from its precursor kininogen. An excess of bradykinin leads to fluid leakage from blood vessels, causing swelling of tissues typical of HAE.Ecallantide suppresses this pathogenetic mechanism by selectively and reversibly inhibiting the activity of plasma kallikrein.https://www.creative-peptides.com/product/ecallantide-item-10-101-160-33646.html






City:	Shirley[US]
Location:

Aug 09 2019	HLA-A_24_02 CMV pp65 tetramer-QYDPVAALF-PE labeled	482
Aug 09 2019	H-2Db LCMV gp33 tetramer-KAVYNFATC-APC labeled	497
Aug 09 2019	H-2Kb TRP-2 tetramer-SVYDFFVWL-PE labeled	466
Aug 09 2019	H-2Db WT1 tetramer-RMFPNAPYL-PE labeled	394
Aug 09 2019	H-2Kb HBV core tetramer-MGLKFRQL-APC labeled	476
Aug 09 2019	T-Select H-2Kb Negative (SIY) tetramer-SIYRYYGL-PE labeled	447
Aug 09 2019	T-Select H-2Kb MuLV p15E tetramer-KSPWFTTL-PE labeled	480
Aug 09 2019	T-Select H-2Kb OVA tetramer-SIINFEKL-APC labeled	510
Aug 09 2019	T-Select HLA-A_24_02 survivin-2B tetramer-AYACNTSTL-APC labeled	447
Aug 09 2019	T-Select HLA-A_02_01 CMV pp65 tetramer-NLVPMVATV-PE labeled	480